Allurefem Holding Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Allurefem Holding.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Construction earnings growth	12.2%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

Recent updates

A Look At The Fair Value Of Allurefem Holding Limited (HKG:8305)

Jan 08

There's Reason For Concern Over Allurefem Holding Limited's (HKG:8305) Massive 28% Price Jump

Nov 01

Revenues Not Telling The Story For Allurefem Holding Limited (HKG:8305) After Shares Rise 28%

Aug 19

Allurefem Holding Limited's (HKG:8305) Shares Climb 43% But Its Business Is Yet to Catch Up

Jun 07

What Allurefem Holding Limited's (HKG:8305) P/S Is Not Telling You

Apr 18

Optimistic Investors Push Allurefem Holding Limited (HKG:8305) Shares Up 41% But Growth Is Lacking

Jan 03

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Allurefem Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SEHK:8305 - Analysts future estimates and past financials data (HKD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2024	136	-14	11	11	N/A
3/31/2024	148	-28	N/A	N/A	N/A
12/31/2023	143	-30	7	7	N/A
9/30/2023	169	-33	N/A	N/A	N/A
6/30/2023	164	-36	8	8	N/A
3/31/2023	186	-22	N/A	N/A	N/A
12/31/2022	185	-25	7	7	N/A
9/30/2022	156	-47	N/A	N/A	N/A
6/30/2022	181	-43	-11	-11	N/A
3/31/2022	161	-44	N/A	N/A	N/A
12/31/2021	154	-43	-21	-21	N/A
9/30/2021	182	-5	N/A	N/A	N/A
6/30/2021	178	1	-3	-2	N/A
3/31/2021	159	-1	N/A	N/A	N/A
12/31/2020	173	-2	10	15	N/A
9/30/2020	178	-7	N/A	N/A	N/A
6/30/2020	198	-8	-6	2	N/A
3/31/2020	222	-2	N/A	N/A	N/A
12/31/2019	220	2	-34	-27	N/A
9/30/2019	239	19	N/A	N/A	N/A
6/30/2019	236	15	-25	-20	N/A
3/31/2019	238	12	N/A	N/A	N/A
12/31/2018	252	13	-9	-8	N/A
9/30/2018	238	4	N/A	N/A	N/A
6/30/2018	205	4	-21	-20	N/A
3/31/2018	189	4	N/A	N/A	N/A
12/31/2017	179	4	N/A	3	N/A
12/31/2016	134	11	N/A	3	N/A
12/31/2015	130	7	N/A	2	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 8305's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if 8305's earnings are forecast to grow faster than the Hong Kong market

High Growth Earnings: Insufficient data to determine if 8305's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 8305's revenue is forecast to grow faster than the Hong Kong market.

High Growth Revenue: Insufficient data to determine if 8305's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 8305's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/10 11:12
End of Day Share Price	2025/01/10 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Allurefem Holding Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

Allurefem Holding Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Tong Kee (Holding) Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2020

Recent updates

Now 28% undervalued

A Look At The Fair Value Of Allurefem Holding Limited (HKG:8305)

Allurefem Holding Limited Appoints Liang Bin as Non- Executive Director

New major risk - Share price stability

Allurefem Holding Limited has completed a Follow-on Equity Offering in the amount of HKD 11.55 million.

Allurefem Holding Limited has filed a Follow-on Equity Offering in the amount of HKD 11.55 million.

There's Reason For Concern Over Allurefem Holding Limited's (HKG:8305) Massive 28% Price Jump

Allurefem Holding Limited Appoints Shen Peng as Chief Executive Officer

Allurefem Holding Limited Appoints Shen Peng as Chief Executive Officer

Revenues Not Telling The Story For Allurefem Holding Limited (HKG:8305) After Shares Rise 28%

First half 2024 earnings released: EPS: HK$0.001 (vs HK$0.014 loss in 1H 2023)

Allurefem Holding Limited Announces Resignation of Heung Joe Tung as Non-Executive Director

Allurefem Holding Limited to Report First Half, 2024 Results on Aug 02, 2024

Allurefem Holding Limited's (HKG:8305) Shares Climb 43% But Its Business Is Yet to Catch Up

New major risk - Share price stability

What Allurefem Holding Limited's (HKG:8305) P/S Is Not Telling You

Full year 2023 earnings released: HK$0.029 loss per share (vs HK$0.023 loss in FY 2022)

Allurefem Holding Limited, Annual General Meeting, May 14, 2024

Allurefem Holding Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Optimistic Investors Push Allurefem Holding Limited (HKG:8305) Shares Up 41% But Growth Is Lacking

Third quarter 2023 earnings released: HK$0.001 loss per share (vs HK$0.004 loss in 3Q 2022)

Allurefem Holding Limited has filed a Follow-on Equity Offering in the amount of HKD 15.12 million.

Allurefem Holding Limited to Report Q3, 2023 Results on Nov 10, 2023

Is Allurefem Holding (HKG:8305) A Risky Investment?

Allurefem Holding Limited Appointment of Wang Tianwei as President of Greater China Region

Allurefem Holding Limited Appointment of Wang Tianwei as President of Greater China Region

Second quarter 2023 earnings released

Now 28% undervalued

Tong Kee (Holding) Limited to Report Q2, 2023 Results on Aug 11, 2023

A Look At The Fair Value Of Tong Kee (Holding) Limited (HKG:8305)

Now 24% undervalued

First quarter 2023 earnings released: HK$0.001 loss per share (vs HK$0.004 loss in 1Q 2022)

Now 20% undervalued

Now 27% undervalued after recent price drop

Less than half of directors are independent

Tong Kee (Holding) Limited to Report Q3, 2022 Results on Nov 15, 2022

Would Tong Kee (Holding) (HKG:8305) Be Better Off With Less Debt?

Second quarter 2022 earnings released: EPS: HK$0 (vs HK$0 in 2Q 2021)

Tong Kee (Holding) Limited to Report Q2, 2022 Results on Aug 10, 2022

CEO, Chairman & Compliance Officer recently bought HK$364k worth of stock

Insider recently sold HK$40m worth of stock

Would Tong Kee (Holding) (HKG:8305) Be Better Off With Less Debt?

First quarter 2022 earnings released: HK$0.004 loss per share (vs HK$0.003 loss in 1Q 2021)

Less than half of directors are independent

Tong Kee (Holding) Limited to Report Q1, 2022 Results on May 04, 2022

Is Tong Kee (Holding) (HKG:8305) Using Too Much Debt?

Third quarter 2021 earnings released: HK$0.001 loss per share (vs HK$0.006 profit in 3Q 2020)

Tong Kee (Holding) (HKG:8305) Is Making Moderate Use Of Debt

First quarter 2021 earnings released: HK$0.003 loss per share (vs HK$0.005 loss in 1Q 2020)

Is Tong Kee (Holding) (HKG:8305) Using Too Much Debt?

Full year 2020 earnings released: HK$0.003 loss per share (vs HK$0.003 profit in FY 2019)

Tong Kee (Holding) Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2020

Tong Kee (Holding) Limited to Report Fiscal Year 2020 Results on Mar 22, 2021

Third quarter 2020 earnings released: EPS HK$0.006

Tong Kee (Holding) Limited to Report Q3, 2020 Results on Nov 09, 2020

Earnings released

Tong Kee (Holding) Limited to Report Q2, 2020 Results on Aug 10, 2020